ICU Medical Valuation
| ICUI Stock | USD 171.96 2.85 1.63% |
At this time, the entity appears to be overvalued. ICU Medical retains a regular Real Value of $162.93 per share. The prevalent price of the entity is $171.96. Our model calculates the value of ICU Medical from analyzing the entity fundamentals such as operating margin of 0.04 %, and Return On Asset of 0.0066 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ICU Medical's price fluctuation is very steady at this time. Calculation of the real value of ICU Medical is based on 3 months time horizon. Increasing ICU Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ICU Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ICU Stock. However, ICU Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 171.96 | Real 162.93 | Hype 174.02 | Naive 178.43 |
The intrinsic value of ICU Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence ICU Medical's stock price.
Estimating the potential upside or downside of ICU Medical helps investors to forecast how ICU stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ICU Medical more accurately as focusing exclusively on ICU Medical's fundamentals will not take into account other important factors: ICU Medical Total Value Analysis
ICU Medical is currently anticipated to have valuation of 5.65 B with market capitalization of 4.27 B, debt of 1.7 B, and cash on hands of 285.59 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ICU Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.65 B | 4.27 B | 1.7 B | 285.59 M |
ICU Medical Investor Information
About 96.0% of the company shares are owned by institutional investors. The book value of ICU Medical was currently reported as 83.76. The company has Price/Earnings To Growth (PEG) ratio of 1.7. ICU Medical recorded a loss per share of 2.92. The entity had not issued any dividends in recent years. The firm had 3:2 split on the 18th of March 2002. Based on the analysis of ICU Medical's profitability, liquidity, and operating efficiency, ICU Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.ICU Medical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of ICU signifies not a very effective usage of assets in November.ICU Medical Ownership Allocation
ICU Medical has a total of 24.43 Million outstanding shares. The majority of ICU Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in ICU Medical to benefit from reduced commissions. Therefore, third-party entities are subject to a different set of regulations than regular investors in ICU Medical. Please pay attention to any change in the institutional holdings of ICU Medical as this could imply that something significant has changed or is about to change at the company. Also note that almost nine hundred twenty-three thousand two hundred seventy-six invesors are currently shorting ICU Medical expressing very little confidence in its future performance.ICU Medical Profitability Analysis
The company reported the previous year's revenue of 2.26 B. Net Loss for the year was (29.66 M) with profit before overhead, payroll, taxes, and interest of 697.76 M.About ICU Medical Valuation
An absolute valuation paradigm, as applied to ICU Stock, attempts to find the value of ICU Medical based on its fundamental and basic technical indicators. By analyzing ICU Medical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ICU Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ICU Medical. We calculate exposure to ICU Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ICU Medical's related companies.ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California. I C operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 15300 people.
ICU Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 24.1 M | |
| Quarterly Earnings Growth Y O Y | -0.238 | |
| Forward Price Earnings | 26.8097 |
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |